Clinical Trials on Anterior Wall Myocardial Infarction in Belgium

Total 660 results

Terumo Europe N.V.
Cromsource

Completed

DIStal Versus COnventional RADIAL Access for Coronary Angiography and Intervention

Coronary Disease

Italy, Belgium, United Kingdom, Hungary, Japan, Czechia, Germany, Netherlands, North Macedonia, Switzerland
Cervical Artery Dissections and Ischemic Stroke...

Unknown

Looking For Genetic and Environmental Risk Factors and Therapeutic Aspects in Cervical Artery Dissections (CADISP)

Stroke | Brain Infarction | Cervical Artery Dissection

Argentina, Belgium, Finland, France, Germany, Italy, Switzerland, Turkey, United Kingdom
Medinol Ltd.

Completed

Study of BioNIR Drug Eluting Stent System in Coronary Stenosis (BIONICS)

Coronary Artery Stenosis

United States, Israel, Canada, Netherlands, Belgium, Italy, Poland, Spain
CoreAalst BV

Recruiting

Precise Procedural and PCI Plan (P4) (P4)

Coronary Artery Disease

Denmark, United Kingdom, Belgium, Italy, Hungary
Sanofi
Bristol-Myers Squibb

Completed

ARCHIPELAGO: Irbesartan in Patients With Acute Coronary Syndrome Without ST Segment Elevation

Myocardial Ischemia | Hypertension

France, Spain, Italy, Belgium, Canada, Germany, Hungary, United States, Netherlands, United Kingdom, Switzerland
Thorax Centrum Twente

Unknown

Bioresorbable Polymer ORSIRO Versus Durable Polymer RESOLUTE ONYX Stents (BIONYX)

Coronary Artery Disease | Angina Pectoris | Acute Coronary Syndrome | Unstable Angina Pectoris | Coronary Stenosis | Coronary Restenosis

Netherlands, Israel, Belgium
Shockwave Medical, Inc.

Completed

Shockwave Coronary Lithoplasty® Study (Disrupt CAD II)

Coronary Artery Disease

Sweden, France, United Kingdom, Spain, Belgium, Denmark, Germany, Italy, Netherlands
Amsterdam UMC, location VUmc

Recruiting

PeRcutaneous cOronary Intervention of Native Coronary arTery Versus Venous Bypass Graft in Patients With Prior CABG (PROCTOR)

Coronary Artery Disease

Belgium, Netherlands, United Kingdom, Germany, Poland
Gilead Sciences

Completed

Switching From a Tenofovir Disoproxil Fumarate (TDF) Containing Regimen to Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Alafenamide (E/C/F/TAF) Fixed-Dose Combination (FDC) in Virologically-Suppressed, HIV-1 Infected Adults Aged ≥ 60 Years

HIV-1 Infection

Spain, United Kingdom, Italy, France, Belgium
Abivax S.A.

Completed

ABX464 in Fully Controlled HIV Infected Patients Treated With Boosted Protease Inhibitor Treatment

HIV Infection

Spain, Belgium, France
International AIDS Vaccine Initiative
Children's Hospital of Philadelphia; Nationwide Children's Hospital; Targeted...

Completed

Safety and Immunogenicity Study of tgAAC09, a Gag-PR-RT AAV HIV Vaccine (A001)

HIV Infection

Belgium, Germany, India
Medinol Ltd.

Completed

PIONIR Study (Presillion™ and Presillion™ Plus Stent Systems)

Ischemic Heart Disease

Israel, Sweden, Belgium, Germany
The University of Texas Health Science Center,...
Abbott Medical Devices

Completed

CONTRAST (Can cONTrast Injection Better Approximate FFR compAred to Pure reSTing Physiology?) (CONTRAST)

Coronary Artery Disease

Korea, Republic of, Italy, Sweden, United States, Belgium, France, Netherlands, Portugal, United Kingdom
University Hospital, Saarland
B.Braun Vascular Systems, Berlin, Germany

Completed

DEBlue Stent vs Cypher Stent in the Treatment of Advanced Coronary Artery Disease (PEPCADIII)

Coronary Artery Disease

United Kingdom, Germany, Belgium, Spain, Czech Republic, France, Netherlands, Sweden
Janssen Vaccines & Prevention B.V.
Bavarian Nordic

Terminated

Safety, Reactogenicity and Immunogenicity of Adenovirus Serotype 26 (Ad26)- and Modified Vaccinia Ankara (MVA)-Vectored Vaccine Components in Otherwise Healthy Women With HPV16 or HPV18 Infection of the Cervix

Human Papillomavirus Infections

United States, Belgium
GlaxoSmithKline

Completed

A Study of Patient Management in HIV-1 Infected Patients Found to Have the Genetic Marker HLA-B*5701

HIV Infection

Spain, Slovenia, Belgium, Italy, Russian Federation, Austria, Switzerland
Novartis

Completed

Safety and Efficacy of APL180 in Healthy Volunteers and Patients With Coronary Heart Disease (CHD)

Coronary Heart Disease

Netherlands, South Africa, United States, Belgium, Denmark, Israel, United Kingdom
OrbusNeich

Completed

Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth

Coronary Artery Disease | Coronary Artery Stenosis

Netherlands, Belgium, United Kingdom, France, Germany, Austria
Sanofi

Terminated

Hydroxychloroquine in Outpatient Adults With COVID-19

Coronavirus Infection

United States, Belgium, France, Netherlands
CID - Carbostent & Implantable Devices

Completed

International Randomized Comparison Between DES Limus Carbostent and Taxus DES in the Treatment of De-novo Coronary Lesions (NEXT)

Stable Angina | Unstable Angina | Documented Silent Ischemia

France, Germany, Belgium, Italy
University of North Carolina, Chapel Hill
Bill and Melinda Gates Foundation

Completed

Limiting Adverse Birth Outcomes in Resource-Limited Settings (LABOR)

Respiratory Infection | Labor and Delivery | Birth Outcomes

Ghana, India, Zambia
Ottawa Heart Institute Research Corporation
Far Eastern Memorial Hospital; London Health Sciences Centre; Medtronic; The Methodist... and other collaborators

Recruiting

The Minimally Invasive Coronary Surgery Compared to STernotomy Coronary Artery Bypass Grafting Trial (MIST)

Coronary Artery Disease

United States, Belgium, Canada, China, Germany, India, Japan, Singapore, Taiwan
Biotronik AG

Unknown

First in Man Study of the DREAMS 2nd Generation Drug Eluting Absorbable Metal Scaffold (BIOSOLVE-II) (BIOSOLVE-II)

Coronary Artery Disease | Coronary Artery Stenosis

Spain, Denmark, Germany, Brazil, Belgium, Netherlands, Singapore, Switzerland
Pierre Fabre Medicament

Completed

Effect of F2695 on Functional Recovery After Ischemic Stroke (LIFE)

Ischemic Stroke

Spain, France, Switzerland, Germany, Sweden, Italy, Czech Republic, Portugal, Belgium, Hungary, Russian Federation
Fondazione Penta UK
UCL Great Ormond Street Institute of Child Health

Recruiting

Pregnancy and Neonatal Outcomes Following Antenatal Exposure to Raltegravir: a Pooled Analysis From the European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC)

HIV Infections

Spain, Switzerland, United Kingdom, Belgium, Italy, Romania, Russian Federation
NEAT ID Foundation
ViiV Healthcare

Completed

An Open-Label, Multi-Centre, Randomised, Switch Study to Evaluate the Virological Efficacy Over 96 Weeks Of 2-Drug Therapy With DTG/RPV FDC in Antiretroviral Treatment-Experienced HIV-1 Infected Subjects Virologically Suppressed With NNRTIs Resistance Mutation K103N (WISARD)

HIV-1-infection

Spain, Belgium, France, Germany, Italy, United Kingdom
Bharat Biotech International Limited

Active, not recruiting

Phase III Study of BBV154 Intranasal Vaccine in Healthy Volunteers (Nasal154PH3)

COVID-19 Respiratory Infection

India
Labo'Life

Recruiting

Randomized, Placebo-controlled, Double-blind Study of 2LHERP® in Orofacial Herpes Infections. (HEARTH-OF)

Herpes Simplex

Belgium
UMC Utrecht
MedImmune LLC

Completed

Advanced Understanding of Staphylococcus Aureus Infections in Europe - Surgical Site Infections (ASPIRE-SSI)

Staphylococcus Aureus | Surgical Wound Infection

United Kingdom, Netherlands, Spain, Czechia, Serbia, Belgium, France, Estonia, Italy, Romania
HeartFlow, Inc.
Duke Clinical Research Institute

Completed

The PLATFORM Study: Prospective LongitudinAl Trial of FFRct: Outcome and Resource IMpacts) (PLATFORM)

Coronary Artery Disease

United States, Germany, United Kingdom, Denmark, Belgium, Austria, France, Italy
Ceric Sàrl
Boston Scientific Corporation

Completed

Efficacy and Safety of New Generation Drug Eluting Stents Associated With an Ultra Short Duration of Dual Antiplatelet Therapy. Design of the Short Duration of Dual antiplatElet Therapy With SyNergy II Stent in Patients Older Than 75 Years Undergoing Percutaneous Coronary Revascularization. (SENIOR)

Acute Coronary Syndrome | Stable Angina | Silent Myocardial Ischemia

France, Spain, Belgium, Switzerland, United Kingdom, Latvia, Finland, Italy, North Macedonia
ExThera Medical Europe BV
ExThera Medical Corporation; Vivantes Clinic Neukölln

Recruiting

Reduction of Pathogen Load From the Blood in Septic Patients With Suspected, Life-threatening Bloodstream Infection

Bloodstream Infection

France, Germany, Netherlands, Austria, Belgium, Italy, Poland, Spain, United Kingdom
Maastricht University Medical Center
FABPulous B.V.

Completed

Incremental Value of Point of Care H-FABP Testing in Primary Care Patients Suspected of Acute Coronary Syndrome (RAPIDA)

Acute Coronary Syndrome | Thoracic Diseases | Angina Pectoris, Stable | Angina Pectoris, Unstable

Belgium, Netherlands
REVA Medical, Inc.

Active, not recruiting

Safety & Performance Study of the FANTOM Sirolimus-Eluting Bioresorbable Coronary Scaffold (FANTOM II)

Coronary Artery Disease

Netherlands, Denmark, Poland, Germany, Australia, France, Belgium, Brazil
Janssen Research & Development, LLC

Completed

A Study to Assess Intrahepatic and Peripheral Changes of Immunologic and Virologic Markers in Chronic Hepatitis B Virus Infection (INSIGHT)

Hepatitis B

France, United States, Belgium, United Kingdom, Poland, New Zealand, Germany, Italy, Canada
Bracco Diagnostics, Inc

Completed

Evaluation of Safety and Efficacy of Lumason/SonoVue in Subjects Undergoing Pharmacologic Stress BR1-142

Coronary Artery Disease

Canada, United States, Belgium, United Kingdom
Labo'Life

Recruiting

Study of 2LPAPI® on the Clearance of Genital HR-HPV Infections. (PAPION)

Human Papilloma Virus

Belgium
Genticel

Completed

Phase II Study of HPV Therapeutic Vaccine in HPV Infected Women With Normal Cytology or ASCUS/LSIL (RHEIA-VAC)

Genital Infection Viral | HUMAN PAPILLOMA VIRUS

Belgium, Spain, Finland, France, United Kingdom, Germany, Netherlands
University Hospital Inselspital, Berne
European Cardiovascular Research Center

Completed

GLOBAL LEADERS Adjudication Sub-Study (GLASSY)

Coronary Artery Disease | Platelet-aggregation Inhibitors

Bulgaria, Switzerland, Austria, Belgium, Germany, Italy, Netherlands, Poland, United Kingdom
Gilead Sciences

Completed

Renal Effect of Stribild or Other Tenofovir DF-containing Regimens Compared to Ritonavir-boosted Atazanavir Plus Abacavir/Lamivudine in Antiretroviral Treatment-naive HIV-1 Infected Adults

HIV-1 Infection

France, United Kingdom, Spain, Belgium, Ireland
Micell Technologies

Completed

Clinical Investigation of the MiStent Drug Eluting Stent (DES) in Coronary Artery Disease (DESSOLVE-II)

Coronary Artery Disease

New Zealand, Netherlands, United Kingdom, France, Belgium, Sweden
University Hospital, Ghent
Horizon 2020 - European Commission; Universidad de Cuenca

Not yet recruiting

Hospital-based Validation of the New ELEVATE Screening Tool in Belgium and Ecuador (ELEVATE-Pilot)

Cervical Cancer | HPV Infection

Belgium, Ecuador
Hasselt University
Jessa Hospital; Ziekenhuis Netwerk Antwerpen (ZNA); Ziekenhuis Oost-Limburg; Algemeen... and other collaborators

Recruiting

HCV Reinfection After DAA Therapy in PWID in Belgium (REINF_HCV)

Drug Use | Hepatitis C Virus Infection, Response to Therapy of

Belgium
PENTA Foundation
King's College Hospital NHS Trust; Karolinska Institutet; Hospital General Universitario... and other collaborators

Recruiting

European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC) SARS-CoV-2 Antibody Study Protocol. Covid-19 (SARS-Cov2)

Sars-Cov2 Antibodies in Children and Adolescents Living With HIV

Spain, United Kingdom, South Africa, Belgium, Greece, Ukraine
Erasme University Hospital
University of Liege; Universitair Ziekenhuis Brussel; University Hospital, Lille and other collaborators

Completed

The Bacteriuria in Renal Transplantation (BiRT) Study: A Trial Comparing Antibiotics Versus no Treatment in the Prevention of Symptomatic Urinary Tract Infection in Kidney Transplant Recipients With Asymptomatic Bacteriuria (BiRT)

Bacteriuria | Urinary Tract Infections | Kidney Transplantation | Asymptomatic Bacteriuria

Belgium, France
Gilead Sciences

Completed

Study to Evaluate Switching From an E/C/F/TAF Fixed-Dose Combination (FDC) Regimen or a TDF Containing Regimen to B/F/TAF FDC in Human Immunodeficiency Virus-1 (HIV-1) Infected Participants Aged ≥ 65 Years

HIV-1 Infection

Spain, United Kingdom, France, Italy, Belgium
University Hospital Inselspital, Berne

Completed

Independent OCT Registry on Very Late Bioresorbable Scaffold Thrombosis (INVEST)

Drug-Eluting Stents | Coronary Thrombosis | Tomography, Optical Coherence

Austria, Belgium, France, Germany, Hong Kong, Italy, Netherlands, Singapore, Spain, Switzerland
Boston Scientific Corporation

Completed

Non-inferiority Trial to Assess the Safety and Performance of the Evolution Coronary Stent (Evolve)

Coronary Artery Disease

Spain, Belgium, France, Australia, United Kingdom, Sweden, New Zealand, Denmark, Poland
Janssen Vaccines & Prevention B.V.

Completed

A Study of an Ad26.RSV. preF-based Vaccine in Adults Aged 18 to 59 Years, Including Adults at High Risk for Severe RSV Infection

Respiratory Syncytial Virus Infection Prevention

Germany, Spain, Belgium, Sweden, United States
Meril Life Sciences Pvt. Ltd.

Unknown

BioMime Vs. Xience Randomised Control Clinical Study (meriT-V)

Coronary Artery Disease

United Kingdom, Brazil, Spain, Macedonia, The Former Yugoslav Republic of, Belgium, Czechia, Latvia, Netherlands, Poland

Clinical Trials on Anterior Wall Myocardial Infarction in Belgium

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Netherlands

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations